methotrexate
DrugTwo dose methotrexate
Other names: Rheumatrex Dose Pack, Trexall
NCT Number: NCT00194272
This study examines the safety and acceptability of a novel "two dose" regimen of methotrexate to treat ectopic pregnancy.
Looking for future studies?
Notify MeFemale
Interventional
Phase 3
University of Southern California Women's and Children's Hospital, Los Angeles, California, United States
The regimen is an attempt to create a middle ground between the 2 commonly used regimens - "single dose" and "multi dose". The "multi dose" regimen is more effective, but the "single dose" regimen is more convenient for patients and has fewer side effects.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Two dose methotrexate
Other names: Rheumatrex Dose Pack, Trexall
Time frame: Till quantitative bhCG values fall to zero or below 5mIU/mL
Time frame: Till quantitative bhCG values fall to zero or below 5mIU/mL
University of Pennsylvania
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06559280
Ectopic Pregnancy, Female Urogenital Diseases and Pregnancy Complications
Fuzhou, Fujian, China
View Trial DetailsNCT06504082
Ectopic Pregnancy, Female Urogenital Diseases and Pregnancy Complications
Van, Tuşba, Turkey (Türkiye)
View Trial DetailsNCT04739956
Anxiety, Anxiety Disorders
London, United Kingdom
View Trial DetailsNCT05039853
Abortion, Spontaneous, Ectopic Pregnancy
London, United Kingdom
View Trial Details